Surprisingly, lipid parameters and body weight were improved in animals treated with 19 for 25 days at doses of 25 mg/kg and 50 mg/kg, demonstrating the potential of dual GK/PPARγ activators as drugs for treatment of MetS (Lei et al., 2015). Here, PPARG is linked to metabolic syndrome.